Vaccines for RCC: Rationale and Clinical Update

By EditorApril 25, 2015No Comments1 Min Read

Kidney Cancer Meeting Lyon, France 2015: Vaccines for RCC: Rationale and Clinical Update Hans Hammers M.D. / Ph.D.
Assistant Professor: Medical Oncology, Chemical Therapeutics
Johns Hopkins Kimmel Cancer Center

Vaccines for RCC: Rationale and Clinical Update

ASH 2025 MDS/ALL Highlights: Verona Trial Lessons & CLEVER Pathway | Dr. Jeyakumar

Bispecific Antibodies Cancer Therapy: 2025 Advances

Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani

Vaccines for RCC: Rationale and Clinical Update

Related Posts

ASH 2025 MDS/ALL Highlights: Verona Trial Lessons & CLEVER Pathway | Dr. Jeyakumar

Bispecific Antibodies Cancer Therapy: 2025 Advances

Advancing Acute Lymphoblastic Leukemia Treatment with CAR-T Cells: Insights from Dr. Anjali Advani